1800-272-662
Shopping Cart 0
countryflagAU
Login

Surgery Partners Inc

Healthcare US SGRY

12.95USD
-0.35(2.63%)

Last update at 2026-03-10T20:00:00Z

Day Range

12.9113.65
LowHigh

52 Week Range

19.5033.97
LowHigh

Fundamentals

  • Previous Close 13.30
  • Market Cap3068.15M
  • Volume1529236
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA628.70M
  • Revenue TTM3172.90M
  • Revenue Per Share TTM25.13
  • Gross Profit TTM 752.20M
  • Diluted EPS TTM-1.53

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax 147.10M 135.00M 110.30M 81.20M -18.80000M
Minority interest -180.60000M -146.20000M 141.60M -141.60000M 117.40M
Net income -168.10000M -11.90000M 87.00M 70.70M 1.30M
Selling general administrative 138.70M 120.90M 102.20M 104.00M 97.10M
Selling and marketing expenses - - - - -
Gross profit 745.60M 647.50M 574.90M 491.40M 379.80M
Reconciled depreciation 152.60M 116.60M 114.80M 98.80M 94.80M
Ebit 348.80M 328.00M 310.40M 263.10M 143.60M
Ebitda 501.40M 446.10M 460.00M 401.00M 277.80M
Depreciation and amortization 152.60M 118.10M 149.60M 137.90M 134.20M
Non operating income net other - - - - -
Operating income 348.80M 328.00M 345.20M 302.20M 246.60M
Other operating expenses 2864.50M 2415.30M 2179.00M 1898.60M 1626.00M
Interest expense 201.70M 193.00M 234.90M 221.00M 201.80M
Tax provision 134.60M 3.60M 23.30M 10.50M -20.10000M
Interest income - - - - -
Net interest income -201.70000M -205.30000M -234.90000M -221.00000M -201.80000M
Extraordinary items - - - - -
Non recurring - - 1.60M 24.30M 56.20M
Other items - - - - -
Income tax expense 134.60M 0.30M 23.30M 10.50M -20.10000M
Total revenue 3114.30M 2743.30M 2539.30M 2225.10M 1860.10M
Total operating expenses 495.80M 319.50M 214.60M 164.90M 145.70M
Cost of revenue 2368.70M 2095.80M 1964.40M 1733.70M 1480.30M
Total other income expense net -201.70000M -193.00000M -234.90000M -221.00000M -201.80000M
Discontinued operations - - - - -
Net income from continuing ops 12.50M 111.90M 87.00M 70.70M 1.30M
Net income applicable to common shares - - -54.60000M -81.20000M -155.60000M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 7890.00M 7019.10M 6682.10M 6117.60M 5413.20M
Intangible assets 45.70M 54.80M 42.30M 43.70M 46.90M
Earning assets - - - - -
Other current assets 182.40M 110.30M 79.00M 39.30M 27.40M
Total liab 4254.80M 3657.20M 6682.10M 6117.60M 5413.20M
Total stockholder equity 1789.70M 1987.20M 1998.20M 1089.00M 115.60M
Deferred long term liab - - - - -
Other current liab 314.30M 235.10M 239.30M 247.00M 243.20M
Common stock 1.30M 1.30M 1.30M 0.90M 0.50M
Capital stock 1.30M 1.30M 1.30M 0.90M 435.00M
Retained earnings -737.30000M -569.20000M -557.30000M -502.70000M -431.80000M
Other liab - - 35.00M 402.60M 440.60M
Good will 5068.00M 4326.00M 4137.10M 3911.80M 3468.00M
Other assets - - 122.30M 5171.50M 554.00M
Cash 269.50M 195.90M 282.90M 389.90M 317.90M
Cash and equivalents - - - - -
Total current liabilities 624.40M 523.00M 493.40M 536.80M 556.80M
Current deferred revenue - - 3.20M 64.40M 109.80M
Net debt 3433.90M 2865.70M 2646.80M 2904.60M 2879.00M
Short term debt 142.40M 110.90M 99.30M 100.50M 103.60M
Short long term debt 101.40M 73.30M 62.80M 60.40M 64.40M
Short long term debt total 3703.40M 3061.60M 2929.70M 3294.50M 3196.90M
Other stockholder equity 2520.90M 2497.60M 2478.00M 1622.30M 173.40M
Property plant equipment - - 1155.70M 953.80M 854.70M
Total current assets 1119.40M 895.00M 921.00M 946.10M 801.50M
Long term investments 215.40M 184.10M 190.30M 88.70M 90.30M
Net tangible assets - - -1567.80000M 1089.00M -2357.10000M
Short term investments - - - - 90.00M
Net receivables 579.10M 513.60M 456.30M 430.20M 382.20M
Long term debt 3268.90M 2701.80M 2559.00M 2878.40M 2792.40M
Inventory 88.40M 75.20M 71.40M 61.10M 56.40M
Accounts payable 208.70M 177.00M 151.60M 124.90M 100.20M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - 942.70M 880.60M 766.50M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 4.80M 57.50M 76.20M -31.50000M -61.00000M
Additional paid in capital - - - - -
Common stock total equity - - 1.30M 0.90M 435.00M
Preferred stock total equity - - - - -
Retained earnings total equity - - -557.30000M -502.70000M -431.80000M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 57.50M 28.70M 144.20M 59.10M 27.00M
Deferred long term asset charges - - - - -
Non current assets total 6770.60M 6124.10M 5761.10M 5171.50M 4611.70M
Capital lease obligations 333.10M 286.50M 307.90M 355.70M 340.10M
Long term debt total - - 2559.00M 2878.40M 2792.40M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -488.50000M -239.70000M -82.30000M -331.70000M -88.40000M
Change to liabilities - - 0.00000M 0.00000M 0.00000M
Total cashflows from investing activities - - -307.90000M -331.70000M -88.40000M
Net borrowings - - -644.20000M -55.50000M 204.60M
Total cash from financing activities 262.00M -155.20000M 42.10M 316.30M 66.70M
Change to operating activities - - -125.40000M -149.20000M 122.50M
Net income 12.50M -11.90000M 87.00M 70.70M 1.30M
Change in cash 73.60M -87.00000M -107.00000M 71.70M 225.20M
Begin period cash flow 195.90M 282.90M 389.90M 318.20M 93.00M
End period cash flow 269.50M 195.90M 282.90M 389.90M 318.20M
Total cash from operating activities 300.10M 293.80M 158.80M 87.10M 246.90M
Issuance of capital stock 0.00000M 0.00000M 882.90M 581.80M 0.00000M
Depreciation 152.60M 118.10M 114.80M 98.80M 94.80M
Other cashflows from investing activities -22.20000M -6.50000M 83.70M -274.10000M 59.10M
Dividends paid - 0.00000M 146.80M 5.10M 109.60M
Change to inventory - - - - -
Change to account receivables -72.10000M -47.20000M -35.30000M -32.10000M -46.60000M
Sale purchase of stock - - 854.30M -233.50000M -27.40000M
Other cashflows from financing activities -173.50000M -174.70000M -196.60000M 316.30M -146.40000M
Change to netincome - - 45.90M 35.60M 25.30M
Capital expenditures 90.40M 88.80M 80.60M 57.60M 42.90M
Change receivables - - -35.30000M -32.10000M -46.60000M
Cash flows other operating - - -53.60000M -85.90000M 172.10M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - -107.00000M 71.70M 225.20M
Change in working capital -118.90000M -63.50000M -160.70000M -149.10000M 75.90M
Stock based compensation 33.30M 17.70M 18.40M 17.40M 13.20M
Other non cash items 89.10M 235.10M 77.40M 40.40M 83.60M
Free cash flow 209.70M 205.00M 78.20M 29.50M 204.00M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SGRY
Surgery Partners Inc		 -0.35 2.63% 12.95 - 31.15 0.97 1.76 2.11 13.68
HCA
HCA Holdings Inc		 -7.49 1.37% 537.64 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.05 0.36% 14.02 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA		 - -% 54.35 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc		 - -% 9.08 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Surgery Partners Inc

340 Seven Springs Way, Brentwood, TN, United States, 37027

Key Executives

Name Title Year Born
Mr. Wayne Scott DeVeydt Exec. Chairman 1970
Mr. J. Eric Evans CEO & Director 1977
Ms. Jennifer B. Baldock Exec. VP and Chief Admin. & Devel. Officer 1971
Mr. Anthony W. Taparo Chief Growth Officer 1966
Mr. Bradley R. Owens Pres of National Group 1970
Mr. David T. Doherty Exec. VP & CFO 1972
Mr. Varun Gadhok Sr. VP & Chief Information Officer NA
Ms. Roxanne Womack Sr. VP & Chief Compliance Officer NA
Ms. Marissa A. Brittenham Exec. VP & Chief Strategy Officer 1985
Mr. Harrison Bane Group Pres of American NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.